IL21 and rheumatoid arthritis: A different study found that while in some RA patients TNFi therapy was successful and led to decreased Th1, Th17 and IL-21, in other RA patients therapy was unsuccessful and led to expansion of Th1/Th17 lymphocytes, and increased IL-21 [197].